Mycophenolic acid affects basic functions of human keratinocytes in the IMPDH-dependent manner

J Borowczyk1, E Laczna, K Sporniak-Tutak

  • 1a Laboratory of Cell & Tissue Engineering, Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.

Insights

Mycophenolic acid (MPA) impairs skin keratinocyte functions, including proliferation and motility, potentially explaining wound healing issues in patients. Guanine addition reversed these effects, suggesting a link to purine synthesis inhibition.

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Immunosuppressant mycophenolic acid (MPA) is linked to impaired wound healing.
  • The mechanism is thought to involve inflammatory response inhibition, but direct effects on epidermal cells are unclear.

Purpose of the Study:

  • To investigate the direct impact of MPA on human epidermal keratinocyte morphology, proliferation, motility, and differentiation in vitro.
  • To explore the role of de novo purine synthesis inhibition in MPA's effects on keratinocytes.

Main Methods:

  • Keratinocyte proliferation assessed by cell counting.
  • Cell motility measured using time-lapse computer-aided imaging.
  • Morphology analyzed via flow and image cytometry.
  • Differentiation markers evaluated using real-time RT-PCR.

Main Results:

  • MPA caused irreversible inhibition of keratinocyte proliferation and impaired cell locomotion.
  • MPA treatment led to cell enlargement and reduced expression of differentiation markers.
  • These effects were reversible upon guanine supplementation.

Conclusions:

  • MPA directly impairs essential human keratinocyte functions, including proliferation, motility, and differentiation.
  • These impairments are mediated by intracellular guanosine nucleotide depletion.
  • MPA's direct effect on keratinocytes may contribute to wound healing complications in patients.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...